 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Revolution Medicines, Inc. (NASDAQ:RVMD  Get Free Report)s stock price was down 2.2% on Friday . The company traded as low as $29.78 and last traded at $29.81. Approximately 19,932...

Revolution Medicines (NASDAQ:RVMD)  Shares Down 2.2%

Insider Sell: COO Margaret Horn Sells 7,514 Shares of Revolution Medicines Inc (RVMD)

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

JPMorgan ups Revolution Medicines target, adds to Analyst Focus List

This indicator may be signaling RVMD's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

Revolution Medicines (RVMD, $32.89) entered Uptrend as Momentum indicator ascends above 0 level on Sep 12, 2023

Revolution Medicines, Inc. (NASDAQ:RVMD  Free Report)  Equities research analysts at Leerink Partnrs lifted their Q3 2023 earnings estimates for shares of Revolution Medicines in a...

Revolution Medicines, Inc. (NASDAQ:RVMD) Forecasted to Post Q3 2023 Earnings of ($0.92) Per Share

Revolution Medicines, Inc. (NASDAQ:RVMD  Get Free Report) insider Mark A. Goldsmith sold 30,000 shares of the stock in a transaction that occurred on Friday, September 1st. The shares were...

Revolution Medicines, Inc. (NASDAQ:RVMD) Insider Mark A. Goldsmith Sells 30,000 Shares

Revolution Medicines, Inc. (NASDAQ:RVMD  Get Free Report) COO Margaret A. Horn sold 10,000 shares of the firms stock in a transaction dated Thursday, August 31st. The stock was sold at...

Revolution Medicines, Inc. (NASDAQ:RVMD) COO Margaret A. Horn Sells 10,000 Shares

Swiss National Bank lifted its holdings in Revolution Medicines, Inc. (NASDAQ:RVMD  Free Report) by 13.7% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm...

Swiss National Bank Has $3.65 Million Position in Revolution Medicines, Inc. (NASDAQ:RVMD)

Revolution Medicines, Inc. (NASDAQ:RVMD Get Free Report) has received an average recommendation of Moderate Buy from the six ratings firms that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation and five have ...

Revolution Medicines, Inc. (NASDAQ:RVMD) Receives $33.67 Average Price Target from Brokerages

Ameritas Investment Partners Inc. increased its stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD  Free Report) by 16.3% during the first quarter, according to the company in its most...

Ameritas Investment Partners Inc. Has $147,000 Stake in Revolution Medicines, Inc. (NASDAQ:RVMD)

Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Watchers	405
52-Wk Low	$17.47
52-Wk High	$35.50

Market Cap	$3.16B
Volume (M)	640,398.00
52-Wk High	$35.50
52-Wk Low	$17.47

RVMD Revolution Medicines Inc

About

Feed

News

Sentiment

Earnings

Fundamentals